Introduction
Rheumatoid arthritis (RA) is often accompanied by anemia which can be of different origins [1, 2] . Iron deficiency anemia [3, 4] and the anemia of chronic disease (ACD) [5] are frequently associated with active RA. Many studies have been carried out to elucidate the pathogenesis of ACD in RA. Concepts that have been postulated include inhibitory effects of cytokines on erythropoiesis [6] [7] [8] and a decreased erythropoietin responsiveness [2, 9] . Other factors, such as impaired iron release by the mononuelear phagocyte system (MPS) [10] [11] [12] and decreased iron uptake and transferrin binding by erythroblasts [13] , are thought to contribute to the genesis of ACD by reducing erythroblast iron availability.
Correspondence to: A. J. G. Swaak Iron fluxes between different compartments are thought to rely predominantly on transport by transferrin [14] . Transferrin iron saturation, the affinity of transferrin for it receptor and the number of transferrin receptors expressed by erythroblasts determine erythroblast iron uptake in this scheme.
Being a glycoprotein with N-linked glycans, transfertin is subject to the phenomenon of microheterogeneity. This involves structural variation in the carbohydrate moiety of transferrin, which results in a limited number of transferrin isotypes that can be distinguished and quantitated electrophoretically [15] . Alterations in the relative proportions of the transferrin variants, reflecting changes in glycosylation, have been described in pregnancy and in several chronic diseases including RA, hemochromatosis and cancer [15, 16] .
Current data on the microheterogeneity of transferrin suggest that functional properties of transferrin, such as the affinity to its receptor, can be modulated by this phenomenon [14, 17, 18] . This, in turn, may alter the biological activity of transferrin and could, therefore, influence iron delivery to target organs [14, 15, 17, 18] .
In acute and chronic inflammatory conditions, increased synthesis of several positive acute phase glycoproteins (APG's) has been shown to be accompanied by changes in their microheterogeneity [19] [20] [21] [22] [23] . It is proposed that regulation of both synthesis and glycosylation of APG's is mediated by tumor necrosis factor alpha (TNF), interleukin-1 (IL-1), interleukin-6 (IL-6) and transforming growth factor/~i [24] [25] [26] [27] .
In RA the existence of both ACD [4, 9] and alterations in the glycosytation pattern of a number of positive APG's appear to correlate with disease activity [22, 23] , suggesting that changes in glycosylation are a direct consequence of an increase in the rate of synthesis of positive APG's. Transferrin is considered to be a negative acute phase protein [28] . Indeed, in RA patients with active RA and ACD transferrin levels are decreased [5, 12] .
The aim of this study was to assess the relation between the microheterogeneity pattern of transferrin and the serological disease activity in RA, since changes that 196 are postulated to alter iron transport might be operative in ACD in RA.
Patients and methods

Patients. Serum was obtained from 21 healthy volunteers (controls)
and from 25 patients with RA fitting the revised American Rheumatism Association (ARA) criteria [29] . Written informed consent was obtained from all subjects. The patients were divided into three groups. Group 1 comprised nine nonanemic patients with a mean (+ SD) age of 54 + 5 years and a mean (+ SD) disease duration of 6 _ 3 years. Group 2 comprised seven patients with iron deficiency anemia based on the absence of stainable bone marrow iron. The patients in this group had a mean (___ SD) age of 56_ 5 years and a mean (___ SD) disease duration of 6 + 3 years. Group 3 comprised nine patients with ACD based on normal to increased bone marrow iron. The patients in group 3 had a mean (-I-SD) of 59__+ 7 years and a0 a mean (-t-SD) disease duration of 8 -t-4 years. Mean age, sex and mean disease duration did not differ significantly between the three RA groups. All patients used nonsteroidal anti-inflammatory 70 drugs, whereas 18 (72%) were on long-acting antirheumatic drugs. Clinical disease activity was highest in group 3 and lowest in group 1. 6o Other causes of anemia were excluded by history-taking (present or past ulcer disease, other gastrointestinal disease or complaints,
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hypermenorrhoea and hematuria), by checking for stools negative for occult blood, a normal vitamin B12, folic acid, Coombs test, creatinine clearance and absence of microscopic hematuria.
~ g The protocol for this study was accepted by the Medical Ethics .~ 40 Committee of the Dr. Daniel den Hoed Clinic. ~
Laboratory procedures. Erythrocyte parameters and disease activity
were assessed as follows. Hemoglobin (Hb), hematocrit (Ht), reticulocytes, mean cell volume (MCV), serum iron, transferrin, ferritin and erythrocyte sedimentation rate (ESR) were measured using standard laboratory procedures. Iron saturation was determined by means of the ratio, serum iron/total iron binding capacity. C-reactive protein (CRP) was assessed by immunodiffusion techniques and Clq binding was measured by the method of Zubler and Lambert [30] . Bone marrow was aspirated after posterior iliac crest puncture and stained for iron using Perl's Prussian blue staining.
Assessment of transferrin mieroheterogeneity.
Crossed immuno isoelectric focusing was carried out as described previously [15, 31] . Briefly, in the first phase transferrin subfractions were separated by isoelectric focusing on polyacrylamide gelstrips carrying an immobilized pH-gradient. The second phase, which was run perpendicularly to the first, involved a rocket immunoelectrophoresis of all transferrin fractions simultaneously. This resulted in a pattern in which nine transferrin fractions were separated due to differences in sialic acid content; increased sialylation over four residues per molecule indicated increased branching of the glycans attached to the protein [15] . The relative proportions were ascertained by measurement of the areas enclosed by the immunoelectrophoretic peaks, and relative concentrations were derived from combining these data with total transferrin concentration, which had been determined by standard turbidemetric assay. In Fig. 1 , examples are shown of a normal microheterogeneity pattern and of a pattern obtained from a RA patient with ACD. Data obtained were divided into three subgroups: the low sialylated transferrin fractions (LSTf; the sum of 0-, 1-, 2-and 3-sialotransferrin), the 4-sialotransferrin fraction (4-STf; this is the predominant fraction in normal serum) and the highly sialylated transferrin fractions (HSTf; the sum of 5-to 8-sialotransferrin). This simplied classification was based on earlier observations that within these three groups, changes occuring in the relative amounts of transferrin fractions display similar trends [15] , allowing for this simplification of presentation. All microheterogeneity patterns were assessed in duplicate. Statistical analysis. Normally distributed data were compared using Student's t-test and non-parametric data by the Mann-Whitney U-test. Coefficients of correlation were calculated using Spearman's test.
Results
Iron status and RA-disease activity
Patient characteristics are shown in Table 1 . In comparison with group ] ( n o n a n e m i c patients) transferrin was significantly lower in group 3 (ACD) a n d significantly elevated in group 2 (iron deficiency anemia). In all groups, however, transferrin was lower t h a n in controls (mean 38.2 gmol/1). Total transferrin c o n c e n t r a t i o n correlated with ESR (r=0.55, P < 0 . 0 1 ) a n d C R P ( r = -0 . 4 8 , P < 0.05) in group 1 and group 3. Table 2 . Relation between percentages of transferrin subfractions and disease activity and hemoglobin. % LSTf= % low sialylated transferrin fractions; % 4-STf= % 4-sialotransferrin; % HSTf= % highly sialylated transferrin fractions; NS = not significant % LSTf The ferritin level was significantly elevated in group 3 and significantly decreased in group 2 compared to group 1. The values of the iron status in the control group were within the normal range.
Disease activity, as assessed by ESR (although it is known that ESR and Ht correlate negatively to some extent), CRP and Clqba was highest in group 3, intermediate in group 1 and lowest in group 1.
Transferrin microheterogeneity
A shift in transferrin microheterogeneity was evident in all RA groups (see Fig. 2 ). This change was characterized by a significant increase in the percentage of highly sialylated transferrin fractions (% HSTf) (P< 0.01) and a significant decrease of the percentage of 4-sialotransferrin (% 4-STf; P<0.01). The percentage of low sialylated transferrin fractions (% LSTI) was decreased in all groups, but only significantly in group 3 (P< 0.01).
Compared with group 1, the % HSTfwas significantly higher (P < 0.01) and the % 4-STf ws significantly lower in group 3 (P< 0.05). The % LSTfwas significantly lower in group 3 (P<0.01) compared to both groups 2 and group 1. These results showed that the shift to highly branched glycan chains exhibits the same pattern in all RA groups as the degree of disease activity. The shift was most pronounced in group 3, intermediate in group 2 and least pronounced in group 1. Table 2 shows that an increased inflammatory activity was associated with an increased % HSTf and a decreased % 4-STf and % LSTf. An inverse relation was shown between the % HSTf and Hb, whereas the % 4-STf and % LSTf correlated positively with Hb.
Discussion
The aim of this study was to assess transferrin microheterogeneity in RA and to relate this to disease activity. Our results showed that increasing disease activity was associated with preferential synthesis of transferrin variants with highly branched glycan chains. Since the degree of inflammatory activity was highest in ACD, the shift in transferrin microheterogeneity was most pronounced in this group.
It has been shown that qualitative changes in the glycosylation of glycoproteins can be accompanied by changes in their functional properties [21, [32] [33] [34] . During pregnancy, an increment of the highly sialylated transfertin fractions is thought to serve a functional purpose since it coincides with the increase in iron fluxes to both the placenta and the maternal bone marrow [14, 15, 17] . Recent work demonstrated that highly sialylated transferrins have a higher affinity for the transferrin receptor expressed at the maternal side of the placenta (de Jong et al., manuscript in preparation). This receptor is identical to the transferrin receptor isolated from reticulocytes, with respect to molecular size and immunoreactivity [35] . The high correlation between changes in transferrin microheterogeneity and disease activity suggests that the changes in glycosylation are of functional significance. The increased synthesis of highly sialylated transferrin fractions in the face of both the impaired erythroblast iron availability in ACD and the counteractive decrease in total transferrin protein synthesis may, therefore, be viewed as part of the compensatory mechanism attempting to facilitate iron transport to erythroblasts. In accordance with this proposal is the relation between the preferential synthesis of highly sialylated transferrins and the decrease in Hb. Despite this possible compensation, cry-thropoiesis remains impaired; this may be related to inhibitory effects of cytokines. TNF and IL-1 suppress erythroid colony growth in vitro and their serum levels are increased in active RA [6, [36] [37] [38] [39] . Thus, the inhibited erythroblast iron uptake, which has been shown to accompany the diminished erythropoiesis in ACD [13] might be attributed to increased levels of TNF and IL-1.
Alternatively, the decreased iron incorporation by erythroblasts may be related to an impaired erythropoietin (EPO) responsiveness, thought to be present in ACD in RA [2, 9] , since EPO is able to increase transferrin receptor expression by erythroblasts [40] with a concomitant facilitation of iron uptake. An interesting observation in this respect is that treatment of RA patients with ACD with recombinant human erythropoietin (r-Hu-EPO) is accompanied by an increase in serum soluble transferrin receptor (sTIR) levels [41] . It has been shown that sTill levels correlate with tissue Tilt levels and that higher sTill levels may reflect iron deficiency [42] [43] [44] . The increase in sTill levels during r-Hu-EPO therapy might, therefore, indicate an increased erythropoiesis accompanied by a decrease in body iron stores based on increased iron mobilization and iron utilization [41] . Assuming a role for transferrin microheterogeneity in the fine-tuning of iron fluxes, it might be speculated that alterations in the glycosylation pattern of transferrin are associated with changes in sTill levels.
The fact that transferrin is a negative acute phase protein facilitates a second conclusion from the observed shift in microheterogeneity. One of the main characteristics of the acute phase response is the change in the rates of synthesis of plasma glycoproteins [28] . In addition, concomitant alterations are induced in the glycosylation of various positive acute phase glycoproteins (APGs) [19] [20] [21] . In RA for instance, the changes in the carbohydrate moieties of alpha-l-acid glycoprotein and haptoglobin, both positive APGs, are related to the degree of inflammatory activity [22, 23] . It has been shown for numerous glycoproteins, including transferrin, that changes in the carbohydrate moiety are a concomitant feature of increased synthesis, and a linkage between the regulation of gene expression and glycosylation, has been suggested [14, 19] . Our study showed that in active RA posttranslational modification is directed towards increased synthesis of transferrin carrying highly branched glycans, under conditions where translation of the gene has diminished. This indicated that in the acute phase response, although an altered clearance of the various transferrin isotypes cannot be excluded, these processes are regulated by different mechanisms. This is supported by the observed dissociation between the mechanisms that regulate the synthesis of alpha-fetoprotein and el protease inhibitor and their glycosylation [24, 45] .
In the acute phase response, changes in both rate of synthesis and carbohydrate moieties of positive APG's are thought to be mediated by cytokines [24] [25] [26] [27] . Both TNF and IL-6 exert a negative influence on transferrin synthesis in vitro [26, 46] , whereas it is not known whether these cytokines affect the glycosylation of transferrin. Transferrin levels in the three RA groups were lower than in controls and the inverse relation between transferrin and parameters of disease activity confirmed the fact that transferrin is a negative APG. In active RA, TNF and IL-6 levels are elevated and correlate with disease activity [8, 39, 47] . This suggests that TNF and IL-6 might inhibit the synthesis of transferrin in active RA and possibly influence its glycosylation pattern.
In conclusion, our study showed that in RA the induction of both ACD and the shift in transferrin microheterogeneity was related to increased disease activity. As a response to counter-reproductive effects, such as the impaired erythroblast iron uptake and the decrease in transferrin concentration, preferential synthesis of highly sialylated transferrin variants in ACD may serve as a compensatory mechanism to improve erythroblast iron availability.
